Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.
Released: September 07, 2010
Years of using, misusing, and overusing antibiotics and other antimicrobial drugs has led to the emergence of multidrug-resistant “superbugs.” The IOM’s Forum on Microbial Threats held a public workshop April 6-7 to discuss the nature and sources of drug-resistant pathogens, the implications for global health, and the strategies to lessen the current and future impact of these superbugs.
Released: August 31, 2010
The Robert Wood Johnson Foundation Initiative on the Future of Nursing, at the IOM, seeks to build a blueprint for the future of nursing as part of larger efforts to reform the health care system. The Initiative held three public forums to explore challenges and opportunities in the nursing profession. The third forum was held on February 22, 2010 in Houston, and examined nursing education.
Released: August 27, 2010
The Social Security Administration (SSA) uses a screening tool called the Listing of Impairments to identify claimants who are so severely impaired that they cannot work at all and thus immediately qualify for benefits. In this report, the IOM makes several recommendations for improving SSA’s capacity for determining disability benefits more quickly and efficiently using the Listings.
Released: August 23, 2010
Knowing one’s genetic disposition to a variety of diseases, including common chronic diseases, can benefit both the individual and society at large. The IOM’s Roundtable on Translating Genomic-Based Research for Health held a workshop on March 22, 2010, to bring together diverse perspectives on the value of genetic testing, and to discuss its use in clinical practice.
Released: August 10, 2010
The 2010 Gulf of Mexico oil spill is unprecedented, and its effects on the overall health of individuals remain uncertain. The IOM held a public workshop June 22-23 to examine many factors that could impact how public health officials choose to monitor the potential health effects of the Gulf oil spill and related clean-up activities.
Released: August 02, 2010
The IOM held a public workshop October 7-8, 2009, to evaluate the state of clinical research in the U.S. and to identify strategies for improving clinical trials’ efficiency and effectiveness. This document summarizes the workshop.
Released: July 22, 2010
The IOM’s National Cancer Policy Forum held a workshop February 9-10, 2010, to explore the growing importance of precompetitive collaboration in oncology drug development. Speakers discussed the advantages and challenges of collaborating with competitors to achieve goals with the potential to benefit everyone, and offered lessons learned and best practices to facilitate future precompetitive collaboration.
Released: July 09, 2010
The side effects of some drugs may not appear until after the FDA has approved them. In this report, the IOM offers an ethical framework to help the FDA decide when to require clinical trials to assess a drug's safety after it is on the market.
Released: July 08, 2010
Millions of people in sub-Saharan Africa suffer from mental, neurological, and substance use (MNS) disorders, and most do not have the resources to obtain treatment. The Uganda AffiliateMarketIngtools of Sciences and the IOM hosted a workshop to discuss the state of care for MNS disorders in sub-Saharan Africa.
Released: July 07, 2010
At the request of Congress, the IOM will evaluate U.S. global programs to address HIV/AIDS. This report outlines the IOM’s strategic approach for this evaluation.